financetom
Business
financetom
/
Business
/
Nike Bets On Olympics to Boost Performance Sales: Report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nike Bets On Olympics to Boost Performance Sales: Report
Apr 11, 2024 7:09 AM

Nike ( NKE ), Inc. shares are trading higher today. The company reportedly launched Olympic kits for the teams it sponsors and athletes.

The company roped in athletes such as Kenyan marathon star Eliud Kipchoge and British sprinter Dina Asher-Smith, betting that top athletes can help it win more everyday consumers, reported Reuters.

As per the report, this summer’s Olympic Games in Paris offer a fresh chance for Nike ( NKE ) to direct the customers’ attention to its performance products, such as the Alphafly 3 marathon shoe, which retails at $285.

Nike ( NKE ) also plans to provide kits for the athletics teams of Canada, China, Uganda, Kenya, and Germany at the Olympics and basketball for Japan, China, Spain, and France at the Paris Games.

With the focus on the Olympic games, Nike ( NKE ) aims to sell more entry-level and mid-range running shoes and highlighted its Pegasus shoe range, which retails between $130 and $160.

Also, BofA Securities upgraded the stock from Neutral to Buy and raised its price target from $110 to $113.

In March, Nike ( NKE ) revealed plans for a low single-digit decline in revenue for the first half of fiscal 2025.

Also, the company reported third-quarter revenue of $12.429 billion, which was up slightly year-over-year and beat the Street consensus estimate of $12.281 billion.

Investors can gain exposure to the stock via IQ Healthy Hearts ETF ( HART ) and Listed Funds Trust Roundhill S&P Global Luxury ETF .

Price Action: NKE shares are up 2.8% at $91.47 on the last check Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ImmunityBio Partners With BeiGene to Conduct Phase 3 Trial of Lung Cancer Combination Therapy
ImmunityBio Partners With BeiGene to Conduct Phase 3 Trial of Lung Cancer Combination Therapy
Jan 29, 2025
09:04 AM EST, 01/29/2025 (MT Newswires) -- ImmunityBio ( IBRX ) said Wednesday it has entered into a collaboration and supply agreement with BeiGene to conduct a phase 3 clinical trial combining BeiGene's tislelizumab and ImmunityBio's ( IBRX ) Anktiva as a potential therapy for the advanced or metastatic non-small cell lung cancer in patients who have acquired resistance to...
US upstream oil and gas dealmaking hit $105 billion in 2024, Enverus says
US upstream oil and gas dealmaking hit $105 billion in 2024, Enverus says
Jan 29, 2025
HOUSTON (Reuters) - Dealmaking in the U.S. upstream oil and gas industry hit $105 billion in 2024, the third highest annual total ever, but activity slowed in the second half as buyers found fewer targets to acquire, consultancy Enverus said on Wednesday. Last year's total deal value fell sharply behind the whopping $192 billion in mergers and acquisitions done in...
Two bids made to buy Polish broadcaster TVN, Radio Zet reports
Two bids made to buy Polish broadcaster TVN, Radio Zet reports
Jan 29, 2025
WARSAW, Jan 29 (Reuters) - Polish businessman Michal Solowow and media group WP Holding have made offers to buy Polish broadcaster TVN from Warner Bros Discovery Inc ( WBD ) , private broadcaster Radio Zet reported on Wednesday. (Reporting by Anna Koper, Alan Charlish; Editing by Emelia Sithole-Matarise) ...
Bragg Gaming Shares Up 11% in U.S. Pre-Market on Earnings Guidance
Bragg Gaming Shares Up 11% in U.S. Pre-Market on Earnings Guidance
Jan 29, 2025
09:07 AM EST, 01/29/2025 (MT Newswires) -- Bragg Gaming Group's ( BRAG ) share price had jumped 11% at last look Wednesday in Nasdaq pre-market trading as the company expects its revenue and adjusted EBITDA to increase in 2024. The company anticipates a 9% increase in revenue to about 102 million euros and a 1% increase in adjusted EBITDA to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved